These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9496273)

  • 41. Cell-mediated immune reaction to colon altered by bacteria.
    Fink S; Mais RF
    Gut; 1968 Dec; 9(6):629-32. PubMed ID: 4887689
    [No Abstract]   [Full Text] [Related]  

  • 42. [Relation between the isolation of strains of Escherichia coli O157:H7 and the presence of hemorrhagic colitis in children].
    Vázquez V; Arredondo M; Trujillo F; Cravioto A
    Bol Med Hosp Infant Mex; 1987 Aug; 44(8):442-7. PubMed ID: 3307811
    [No Abstract]   [Full Text] [Related]  

  • 43. Role of antibiotics for treatment of inflammatory bowel disease.
    Nitzan O; Elias M; Peretz A; Saliba W
    World J Gastroenterol; 2016 Jan; 22(3):1078-87. PubMed ID: 26811648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ulcerative colitis in apes: A comparison with the human disease.
    Scott GB; Keymer IF
    J Pathol; 1975 Apr; 115(4):241-4. PubMed ID: 808598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of leucocyte migration by antigens from human colon and E. coli O 14 in patients with ulcerative colitis.
    Fixa B; Komárová O; Skaunic V; Nerad M; Kojecký Z; Benỳŝek L
    Scand J Gastroenterol; 1975; 10(5):491-3. PubMed ID: 1098133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Haemorrhagic colitis: detection of verotoxin producing Escherichia coli O157 in a clinical microbiology laboratory.
    Walker CW; Upson R; Warren RE
    J Clin Pathol; 1988 Jan; 41(1):80-4. PubMed ID: 3278016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease.
    Giaffer MH; Holdsworth CD; Duerden BI
    Gut; 1992 May; 33(5):646-50. PubMed ID: 1612481
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Properties of strains of Escherichia coli carried in different phases of ulcerative colitis.
    Cooke EM; Ewins SP; Hywel-Jones J; Lennard-Jones JE
    Gut; 1974 Feb; 15(2):143-6. PubMed ID: 4595080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunologic aspects of ulcerative colitis.
    Huizenga KA; Shorter RG; Spencer RJ
    South Med J; 1970 Aug; 63(8):954-60. PubMed ID: 4916930
    [No Abstract]   [Full Text] [Related]  

  • 50. [Role of lymphocytes in the development of tissue damage in ulcerative colitis].
    Bakowska Z; Bartnik W
    Pol Tyg Lek; 1971 Aug; 26(33):1290-3. PubMed ID: 4937518
    [No Abstract]   [Full Text] [Related]  

  • 51. Remission of histiocytic ulcerative colitis in Boxer dogs correlates with eradication of invasive intramucosal Escherichia coli.
    Mansfield CS; James FE; Craven M; Davies DR; O'Hara AJ; Nicholls PK; Dogan B; MacDonough SP; Simpson KW
    J Vet Intern Med; 2009; 23(5):964-9. PubMed ID: 19678891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vero cytotoxin-producing strains of Escherichia coli.
    Smith HR; Scotland SM
    J Med Microbiol; 1988 Jun; 26(2):77-85. PubMed ID: 3290494
    [No Abstract]   [Full Text] [Related]  

  • 53. [Allergic syndrome in intestinal diseases and efficacy of specific bacterial immunotherapy].
    Nogaller AM; Malygin AG; Molotilov BA
    Ter Arkh; 1981; 53(10):79-83. PubMed ID: 7313969
    [No Abstract]   [Full Text] [Related]  

  • 54. [Role of Clostridium difficile infection in the relapse of ulcerative colitis].
    Vilalta Castel E; Alcázar Montero MS; Navarro Gaspar C; Gimeno Aranguez M
    An Med Interna; 2002 Dec; 19(12):637-9. PubMed ID: 12593034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sulphasalazine does not select for Escherichia coli with adhesive properties in ulcerative colitis.
    Burke DA; Clayden SA; Axon AT
    Lancet; 1988 Oct; 2(8617):966. PubMed ID: 2902414
    [No Abstract]   [Full Text] [Related]  

  • 56. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.
    Davis MK; Andres JM; Jolley CD; Novak DA; Haafiz AB; González-Peralta RP
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Escherichia Coli O:14 and colon hemagglutinating antibodies in inflammatory bowel disease.
    Thayer WR; Brown M; Sangree MH; Katz J; Hersh T
    Gastroenterology; 1969 Sep; 57(3):311-8. PubMed ID: 4897232
    [No Abstract]   [Full Text] [Related]  

  • 58. [Lipid A antibody titers and O antibody titers in Crohn's disease, ulcerative colitis and acute enteritis (author's transl)].
    Schüssler P; Kruis W; Marget W
    Med Klin; 1976 Oct; 71(44):1898-902. PubMed ID: 825710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways.
    Grabig A; Paclik D; Guzy C; Dankof A; Baumgart DC; Erckenbrecht J; Raupach B; Sonnenborn U; Eckert J; Schumann RR; Wiedenmann B; Dignass AU; Sturm A
    Infect Immun; 2006 Jul; 74(7):4075-82. PubMed ID: 16790781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A quantitative comparison of the faecal flora of patients with ulcerative colitis and that of normal persons.
    Cooke EM
    J Pathol Bacteriol; 1967 Oct; 94(2):439-44. PubMed ID: 4965244
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.